Drug Information
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Janus kinase 1 (JAK-1) | Target Info | Modulator | [2] |
| Janus kinase 2 (JAK-2) | Target Info | Modulator | [2] | |
| Tyrosine-protein kinase (PTK) | Target Info | Inhibitor | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89. | |||
| REF 2 | Selective JAK inhibitors in development for rheumatoid arthritis. Expert Opin Investig Drugs. 2014 Aug;23(8):1067-77. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.